BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 9, 2013
View Archived Issues
Noninvasive electroencephalograph for functional brain analysis in monkeys
Read More
Preclinical evaluation of a mixed-mirror image DNA/RNA aptamer to regulate glucose tolerance
Read More
Characterization of an in vitro 3D culture model of human brain development
Read More
Data published from phase II evaluations of a troponin activator in patients with ALS
Read More
Reductions in rheumatic pain seen with willow bark extract STW-33-1
Read More
University of Pennsylvania discloses new ICOS-based CAR inhibitors for cancer
Read More
Italian researchers patent novel oligonucleotides for cancer
Read More
Researchers at Janssen Pharmaceutica prepare novel endothelial lipase inhibitors
Read More
Canadian group patents novel polypeptides binding to prothrombin
Read More
CP-9531 demonstrates efficacy for multiple sclerosis
Read More
PaxVax begins phase III trial challenge studies for single-dose oral cholera vaccine
Read More
Cellular Biomedicine reports phase I/IIa cell therapy trial data for knee osteoarthritis
Read More
Exon-skipping compound PRO-053 begins phase I/II trial for Duchenne muscular dystrophy
Read More
Sobi acquires full rights to Kineret, additional data for Kepivance
Read More
FDA approves Abraxane for advanced pancreatic cancer
Read More
Toa Eiyo and Astellas Pharma set to launch Bisono Tape in Japan
Read More
Genkyotex obtains IND approval for phase II study of GKT-137831
Read More
Diurnal completes pharmacokinetic portion of CATCH trial in congenital adrenal hyperplasia
Read More
QRxPharma to discuss MoxDuo NDA with FDA prior to refiling
Read More
BIOD-123 demonstrates glycemic control comparable to Humalog in phase II study
Read More
FDA grants QIDP designation to Cempra's solithromycin
Read More
Baxter completes acquisition of Gambro
Read More
GenVec withdraws plan of dissolution
Read More
Civitas Therapeutics begins phase IIb study of inhaled levodopa
Read More
Cempra's solithromycin well tolerated in patients with chronic liver disease
Read More